S&P 500 7,490 +1.05% Nasdaq 25,374 +1.59% Dow Jones 52,485 +1.04% FTSE 100 10,868 +1.23% DAX 25,629 +2.11% Nikkei 225 64,362 -0.88% Hang Seng 25,884 +3.69% WTI Crude 84.67 +6.83% Gold 4,107 +1.75% US 10-Year Treasury Yield 4.745 +2.24% S&P 500 7,490 +1.05% Nasdaq 25,374 +1.59% Dow Jones 52,485 +1.04% FTSE 100 10,868 +1.23% DAX 25,629 +2.11% Nikkei 225 64,362 -0.88% Hang Seng 25,884 +3.69% WTI Crude 84.67 +6.83% Gold 4,107 +1.75% US 10-Year Treasury Yield 4.745 +2.24%

LATEST

Lula pledges defense spending so no one invades Brazil as he confirms his candidacy●What Nvidia Could Be Worth on a $1,000 Investment if History Repeats Itself●Consumer goods giant quietly wows investors after terrible streak●An IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should Know●Why Billionaire Stanley Druckenmiller and Wall Street Analysts Love This Biotech Stock●An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know●AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports●An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion●Lula pledges defense spending so no one invades Brazil as he confirms his candidacy●What Nvidia Could Be Worth on a $1,000 Investment if History Repeats Itself●Consumer goods giant quietly wows investors after terrible streak●An IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should Know●Why Billionaire Stanley Druckenmiller and Wall Street Analysts Love This Biotech Stock●An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know●AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports●An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion●

Front Page

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

US Top News and Analysis · 1h ago · 🇺🇸 United States

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.

Read the full story at US Top News and Analysis →

More Front Page

What Nvidia Could Be Worth on a $1,000 Investment if History Repeats Itself

Yahoo Finance · 45m ago

An IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should Know

Yahoo Finance · 53m ago

Why Billionaire Stanley Druckenmiller and Wall Street Analysts Love This Biotech Stock

Yahoo Finance · 1h ago

An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know

Yahoo Finance · 1h ago